ProfileGDS3604 / 494_at
TitleTamoxifen effect on endometrioid carcinomas
OrganismHomo sapiens


stage I endometrioid carcinoma stage II endometrioid carcinoma control oestrogen tamoxifen control oestrogen tamoxifen GSM65277 GSM65279 GSM65281 GSM65283 GSM65284 GSM65285 GSM65287 31% 35% 33% 33% 39% 39% 40% sort by disease state sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM65277EECs from stage I endometrioid carcinomas control rep 2538.831
GSM65279EECs from stage I endometrioid carcinomas oestrogen(E2) rep 2571.635
GSM65281EECs from stage I endometrioid carcinomas tamoxifen(TAM) rep 2559.433
GSM65283EECs from stage II endometrioid carcinomas control rep 2556.533
GSM65284EECs from stage II endometrioid carcinomas oestrogen(E2) rep 1697.839
GSM65285EECs from stage II endometrioid carcinomas oestrogen(E2) rep 2743.939
GSM65287EECs from stage II endometrioid carcinomas tamoxifen(TAM) rep 2814.940